Risk factors

BayFirst Financial relies heavily on government-guaranteed SBA lending, technology partners, and the Florida real estate and insurance markets.

BigBear.ai relies heavily on government contracts and customer concentration, facing risks from long sales cycles and high indebtedness.

Beta Bionics faces significant operating losses, an accumulated deficit of $296.7 million, and relies solely on sales of its recently launched iLet bionic pancreas.

The company's risk profile is dominated by an ongoing formal process to evaluate strategic alternatives, including potential company or asset sales.

Climb Bio is a clinical-stage biotechnology company focused on developing budoprutug for immune-mediated diseases and CLYM116 for IgAN.

Volatility in residential and non-residential construction markets and municipal infrastructure spending directly impacts net sales. Substantial indebtedness and variable interest rates create ongoing financial servicing risks. Complex tax receivable agreements and organizational structures impose significant cash obligations.

Commercialization of DefenCath dominates risk, alongside heavy customer concentration, accumulated deficits, and outsourced manufacturing dependencies.

Corvus Pharmaceuticals relies entirely on the clinical success and funding of its three main product candidates: soquelitinib, ciforadenant, and mupadolimab. The company has a going concern warning with $52.0 million in cash as of December 31, 2024. Heavy dependence on third-party manufacturers, clinical trial subjects, and key executives creates significant operational vulnerability.

CuriosityStream faces significant accumulated operating losses totaling $308.4 million as of December 31, 2024.

Energy Focus relies heavily on supplier Sander Electronics, faces going concern doubts, and has a history of Nasdaq compliance issues.

High customer concentration dominates revenue while heavy near-term debt maturities threaten operations. Extensive reliance on foundries like UMC and Samsung without long-term capacity agreements creates supply vulnerabilities.

GameStop's risks are dominated by extreme stock volatility and potential short squeezes in its Class A Common Stock. The company faces significant exposure to digital asset investments like Bitcoin and stablecoins alongside core retail challenges. Profitability relies heavily on reducing store footprints and managing supply chains amidst intense omnichannel competition.